Gracell Biotechnologies PIPE of ordinary shares and warrants
The company’s ADSs are listed on Nasdaq
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Avon $194 million tender offer
We advised Avon on its tender offer for outstanding 6.95% notes due 2043
Crocs $1.18 billion refinancing term loan facility
We advised the lead arrangers and administrative agent on the refinancing
Sale of majority stake in Engage PEO to Kohlberg & Company
We advised Engage PEO and Lightyear Capital on the transaction
Regency Centers $500 million at-the-market offering
The shares are listed on Nasdaq
Banco Santander $3.5 billion notes offering
We advised Banco Santander on its offering of fixed-rate notes
Allegro MicroSystems $420 million acquisition of Crocus Technology
We are advising Allegro MicroSystems on the acquisition
Recursion Pharmaceuticals $300 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
MicroStrategy $750 million at-the-market offering
The stock is listed on the Nasdaq Global Select Market
Hayward Holdings $317 million secondary offering
The stock is listed on the New York Stock Exchange